Loading insider details...
Beta
Latest Form 4 (Oct 9, 2026): Exercise/Conversion of 4,483 URGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 4,483 | n/a |
| Feb 3, 2026 | UroGen Pharma Ltd. (URGN) | Grant/Award | 32,609 | n/a |
| Oct 9, 2025 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 4,483 | n/a |
| Oct 9, 2024 | UroGen Pharma Ltd. (URGN) | Grant/Award | 13,450 | n/a |
| Mar 14, 2023 | Galera Therapeutics, Inc. (GRTX) | Purchase | 10,000 | $19.6K |
| Feb 28, 2023 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 185,000 | n/a |
| Mar 2, 2022 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 135,000 | n/a |
| Jan 28, 2021 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 82,500 | n/a |
| Feb 4, 2020 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 74,435 | n/a |